semaglutide after roux-en-y gastric bypass weight regain helps patients who gain bariatric surgery The gastrointestinal anatomy after Roux-en-Y

In a trial of valproate in elderly patients with dementia, a significantly higher portion of valproate patients had somnolence compared to placebo

The article says research indicates estrogen influences GLP-1 signaling at multiple levels, including appetite centers and insulin-producing beta cells

Consider speaking with a healthcare professional before taking L-carnitine to boost exercise performance

How GLP-1s support weight loss When a GLP-1 binds to its receptors, it essentially mimics your bodys natural satiety signals

Novo Nordisk is testing an IL6 inhibitor, Ziltivekimab, which cut hsCRP levels by ~80-90% in the phase 2 trial: The phase 3 trial is measuring the hard outcomes: cardiovascular death, myocardial infarction, or stroke, in people with established cardiovascular disease, chronic kidney disease, and persistent inflammation

Prevents worsening of kidney disease Causes weight loss